Cargando…
Association between fibrinogen level and length of stay in patients with lower extremity atherosclerotic disease: a retrospective cohort study
The level of fibrinogen in patients with lower extremity atherosclerosis (LEAD) has been widely identified as a risk factor contributing to adverse outcomes. However, some knowledge gaps remain regarding fibrinogen levels and downstream adverse outcomes, such as length of stay (LOS). We conducted th...
Autores principales: | Wang, Xue, Yang, Yu, Yu, Ling, Pang, Chang, Sun, Wei, Zang, Shuang, Li, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363167/ https://www.ncbi.nlm.nih.gov/pubmed/37481624 http://dx.doi.org/10.1038/s41598-023-39219-x |
Ejemplares similares
-
Association between homocysteine level and length of stay in patients with lower extremity atherosclerotic disease: a retrospective cohort study
por: Wang, Xue, et al.
Publicado: (2023) -
Development and validation of a prediction model for the prolonged length of stay in Chinese patients with lower extremity atherosclerotic disease: a retrospective study
por: Wang, Xue, et al.
Publicado: (2023) -
History of COVID-19 Was Not Associated With Length of Stay or In-Hospital Complications After Elective Lower Extremity Joint Replacement
por: Jungwirth-Weinberger, Anna, et al.
Publicado: (2021) -
A Nomogram Prediction of Length of Hospital Stay in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study
por: Li, Kang, et al.
Publicado: (2021) -
Pre-kidney transplant lower extremity impairment and transplant length of stay: a time-to-discharge analysis of a prospective cohort study
por: Nastasi, Anthony J., et al.
Publicado: (2018)